ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
3.470
+0.200 (6.12%)
At close: Mar 13, 2026, 4:00 PM EDT
3.270
-0.200 (-5.76%)
After-hours: Mar 13, 2026, 6:17 PM EDT
ENDRA Life Sciences Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+764.55%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $38 → $30 | Strong Buy | Maintains | $38 → $30 | +764.55% | Dec 8, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +995.10% | Sep 22, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $50 → $46 | Strong Buy | Maintains | $50 → $46 | +1,225.65% | May 30, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $75 → $50 | Strong Buy | Maintains | $75 → $50 | +1,340.92% | Apr 21, 2025 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $17,500 → $14,000 | Strong Buy | Maintains | $17,500 → $14,000 | +403,358.21% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $175,000 → $15,750 | Strong Buy | Reiterates | $175,000 → $15,750 | +453,790.49% | Mar 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $210,000 → $175,000 | Strong Buy | Maintains | $210,000 → $175,000 | +5,043,127.67% | Apr 7, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $210,000 | Strong Buy | Initiates | $210,000 | +6,051,773.20% | Jul 15, 2019 |